Tag Archive for: transfusion medicine

Meghan Delaney

Meghan Delaney, D.O., M.P.H., receives 2021 James Blundell Award

Meghan Delaney

The British Blood Transfusion Society (BBTS) recognized Meghan Delaney, D.O., M.P.H., division chief of Pathology and Lab Medicine and director of Transfusion Medicine at Children’s National Hospital, with the James Blundell Award.

The James Blundell Award is the most prestigious award given by the BBTS. Introduced in 1984, this award is given to recipients for original research resulting in an important and significant contribution to the body of medical and or scientific knowledge within the field of blood transfusion.

“I am honored to receive this award from the British Blood Transfusion Society,” says Dr. Delaney. “The field of transfusion medicine is dynamic and provides an important part of our healthcare infrastructure.  It’s wonderful to have this recognition and I am grateful to the society for the award.”

She is professor of Pathology and Pediatrics at the George Washington University with over 100 manuscripts, 25 book chapters and over 60 presented abstracts. Dr. Delaney serves as a member of the Board of Directors for the Association for the Advancement of Blood & Biotherapies (AABB), is a Scientific Member of the BEST Collaborative and is a member of the American Board of Pathology Test Development and Advisory Committee. She serves as the chair of the National Institutes of Health’s BLOODSAFE Program that aims to improve access to safe blood in Sub Saharan Africa.

Dr. Delaney received the award on September 14 at the 2021 BBTS Annual Conference, where she presented the lecture titled: “Access to safe blood transfusion in low- and middle-income nations: From ‘big data’ to mosquitos.”

Meghan Delaney

Pathology chief appointed to board of pathology advisory committee

Meghan Delaney

The American Board of Pathology (ABPath) has appointed the chief of Pathology and Laboratory Medicine at Children’s National Health System, Meghan Delaney, D.O., M.P.H., to its Test Development and Advisory Committee (TDAC) for blood banking and transfusion medicine. As a member of the committee, Dr. Delaney will play a role in the development and review of the American Board of Pathology certification exam questions. Physicians selected to serve on the TDAC are established subject matter experts in their subspecialty, with knowledge on the latest advances in the field of pathology and patient care.

“As TDAC members, these physicians play a critical role in the development of the exams and are entrusted with maintaining the integrity of the board-certified designation. The appointment to a TDAC indicates the physician is highly regarded in the field of pathology and exemplifies the utmost standards of care,” states Rebecca L. Johnson, M.D., CEO of the American Board of Pathology.

Dr. Delaney joined Children’s National as Chief of Pathology and Laboratory Medicine in 2017. A diplomate of the American Board of Pathology, with certification in transfusion medicine/blood banking and clinical pathology, she is an active member of several professional societies. She serves as chair of the AABB Transfusion Medicine Subsection Pediatric Subcommittee and as chair of the American Society of Apheresis Applications Committee Pediatric Subcommittee.  Dr. Delaney is also a scientific member of the BEST Collaborative, an associate editor for the journal Transfusion Medicine and a member of the editorial board of Transfusion.

The mission of the American Board of Pathology, as a member of the American Board of Medical Specialties, is to serve the public and advance the profession of pathology, by setting certification standards and promoting lifelong competency of pathologists. Founded in 1936, the ABPath accomplishes this mission by establishing certification and continuing certification standards, as well as, assessing the qualifications of those seeking to obtain voluntary certification in the specialty of pathology.  Since 1971, the ABPath has appointed test committees for each specialty area of pathology. The committee consists of ABPath trustees and other pathologists, or specialty physicians, who are recognized experts in their respective disciplines.